Skip to main content

Table 1 Comparisons of clinical features (N = 334)

From: Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

 

Non-nicorandil group

(n = 218)

Nicorandil group

(n = 116)

P-value

Age (years)

71.7 ± 11.6

69.8 ± 10.5

0.146

Male gender (n, %)

169 (77.5)

86 (74.1)

0.488

Body mass index (kg/cm2)

23.7 ± 4.6

23.9 ± 4.2

0.708

Systolic blood pressure (mmHg)

132.3 ± 36.1

130.8 ± 35.9

0.716

Diastolic blood pressure (mmHg)

76.2 ± 23.3

72.4 ± 21.5

0.144

Heart rate (bpm)

82.2 ± 23.8

77.5 ± 21.2

0.071

New York Heart Association class III or IV (n, %)

5 (2.3)

3 (2.6)

0.868

LVEF (%)

43.3 ± 13.6

45.6 ± 14.5

0.211

LMT lesion (n, %)

9 (4.1)

10 (8.6)

0.134

3VD (n, %)

45 (20.6)

40 (34.5)

0.008

PCI (n, %)

159 (72.9)

86 (74.1)

0.813

CABG (n, %)

27 (12.4)

42 (36.2)

<0.001

Co-morbidity

 Hypertension (n, %)

194 (89.0)

105 (90.5)

0.665

 Diabetes (n, %)

128 (58.7)

79 (68.1)

0.092

 Dyslipidemia (n, %)

193 (88.5)

107 (92.2)

0.286

 Atrial fibrillation (n, %)

64 (29.4)

27 (23.3)

0.235

 Chronic kidney disease (n, %)

151 (69.3)

78 (67.2)

0.704

 Dialysis (n, %)

28 (12.8)

16 (13.8)

0.865

 Anemia (n, %)

141 (64.7)

78 (67.2)

0.639

 Smoking (n, %)

155 (71.1)

74 (63.8)

0.171

Medications

 Angiotensin converting enzyme inhibitors (n, %)

123 (56.4)

71 (61.2)

0.417

 Angiotensin receptor blockers (n, %)

67 (30.7)

36 (31.0)

1.000

 Aldosterone antagonists (n, %)

91 (41.7)

42 (36.2)

0.325

 β-blockers (n, %)

176 (80.7)

102 (87.9)

0.094

 Calcium channel blockers (n, %)

94 (43.1)

47 (40.5)

0.727

 Diuretics (n, %)

153 (70.2)

79 (68.1)

0.694

 Inotropic agents (n, %)

27 (12.4)

11 (9.5)

0.426

 Anti-platelet agents (n, %)

186 (85.3)

113 (97.4)

<0.001

 Anti-coagulations (n, %)

97 (44.5)

50 (43.1)

0.807

 Anti-diabetic agents (n, %)

92 (42.2)

59 (50.9)

0.135

 Statins (n, %)

132 (60.6)

88 (75.9)

0.005

 Nitrates (n, %)

44 (20.2)

34 (29.3)

0.077

Laboratory data

 BNP (pg/ml)a

306.5 (865.1)

377.5 (619.8)

0.374

 C-reactive protein (mg/dl)a

0.32 (1.19)

0.21 (0.78)

0.132

 Total protein (g/dl)

7.0 ± 0.8

7.0 ± 0.7

0.816

 Sodium (mEq/l)

138.2 ± 4.2

138.6 ± 3.5

0.492

  1. LVEF left ventricular ejection fraction, LMT left main trunk, 3VD three-vessel disease, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, BNP B-type natriuretic peptide
  2. aData are presented as median (interquartile range)